Biologically, Fetuin-A serves a dual function: on the one hand, it is a powerful inhibitor of vascular ectopic calcification [8]; on the other hand, it is associated with insulin resistance (IR), type 2 diabetes (T2D), metabolic syndrome (MS) and NAFLD [7,8,9]. Here, AHSG is linked to myeloid sarcoma.